Red Flags vs. Green Flags When Buying Tongkat Ali

It begins, for most Singaporean men, with a recommendation. A colleague mentions it over lunch at a hawker centre. A gym buddy swears by it. A Shopee listing promises “1:200 extract, maximum strength, Tongkat Ali King from Malaysia.” SGD 18.90, free shipping, four-and-a-half stars from 2,300 reviews.

It arrives in three days. Two weeks later, nothing has changed. The product is quietly shelved alongside the protein powder that didn’t taste quite right, and the conclusion reached, incorrectly, is that Tongkat Ali simply does not work.

This story repeats itself thousands of times across Singapore every month. And it represents one of the most costly and preventable errors in the local supplement market: not the decision to try Tongkat Ali, but the decision to buy it without knowing what to look for.

Tongkat Ali (Eurycoma longifolia), known in Malay as “Ali’s walking stick” — a name that carries its own implication — is a flowering plant native to the rainforests of Malaysia, Indonesia, and Thailand. It has been used in traditional Southeast Asian medicine for centuries, primarily as an adaptogen and androgenic tonic.

It is one of the few natural ingredients with a genuinely accumulating body of peer-reviewed clinical evidence. Studies have shown that standardised Tongkat Ali extract can support testosterone levels, improve stress hormone profiles, enhance libido, and improve body composition in men with late-onset hypogonadism and stress-related hormonal suppression.

The keyword in that paragraph is standardised. Because the distance between a clinically validated Tongkat Ali extract and the product in that SGD 18.90 Shopee listing is not a matter of branding. It is a matter of biochemistry, manufacturing rigour, and a supply chain that most consumers never think to interrogate.

The Shopee and Amazon Problem: Volume Without Verification

Singapore’s e-commerce supplement market is, to put it diplomatically, a crowded and largely unpoliced frontier. Shopee, Lazada, and Amazon collectively list hundreds of Tongkat Ali products at any given time, spanning price points from SGD 12 to SGD 180, with packaging ranging from clearly home-branded capsules in zip-lock bags to sophisticated-looking bottles with QR codes and clinical-sounding nomenclature.

The fundamental problem is not that these platforms are malicious — it is that their seller verification systems are structurally incapable of distinguishing between a product manufactured in a GMP-certified facility with third-party biomarker testing and a product that is, effectively, powdered Tongkat Ali root of unknown provenance, unknown age, and unknown eurycomanone content pressed into capsules in an unregistered facility somewhere in Malaysia or China.

Review scores compound the problem rather than solving it. A product that delivers a mild placebo effect to buyers who simultaneously improve their sleep and gym habits will accumulate positive reviews. The causation is misattributed. The product rides a five-star average it did not biochemically earn. Meanwhile, a genuinely high-quality product priced at SGD 90 sits at a lower review volume because fewer people are willing to pay for it without social proof — a vicious cycle that consistently rewards the mediocre and obscures the effective.

Diluted Extracts vs. Standardised Extracts: The Number That Means Nothing

The “extract ratio” gambit is worth understanding in detail, because it has successfully deceived an enormous number of otherwise intelligent consumers globally.

An extract ratio of 1:200 sounds impressive. It suggests that 200 kg of raw Tongkat Ali root were used to produce 1 kg of extract — a concentration process implying potency.

The problem runs deeper than most consumers realise: this ratio tells you almost nothing about what is actually in the final product, and counter to intuition, a higher ratio is not necessarily better. Extract ratios are largely marketing jargon. A 1:200 ratio simply means a large quantity of raw root was processed down into a small quantity of extract, which can just as easily reflect low-quality starting material, aggressive processing that destroys fragile bioactives, or simple over-concentration as it can reflect genuine potency. A 1:200 extract of poor source root can contain less eurycomanone, glycosaponin, and bioactive-peptide content per gram than a 1:20 extract of high-quality source root. Notably, Physta® — the most clinically studied standardised Tongkat Ali extract in the world — is produced at an extraction ratio in the region of 1:20 or less, deliberately, because its potency derives from preserving and quantifying bioactives, not from headline concentration.

A 1:200 extraction of Tongkat Ali using water at the wrong temperature, pH, or duration can produce a product with effectively no eurycomanone — the primary bioactive responsible for testosterone-modulating effects — while a well-executed 1:20 extraction with proper standardisation may contain multiples more.

This matters because eurycomanone is the compound that clinical research has focused on. Research groups in Malaysia have established that the clinically relevant eurycomanone content in a properly standardised water-soluble extract is typically in the range of 0.8% to 1.5% by weight. This became the basis for what the industry now associates with the patented extract Physta®, developed by Biotropics Malaysia in collaboration with the Massachusetts Institute of Technology, which is the most extensively studied standardised Tongkat Ali extract in the world.

Physta® has been the subject of multiple randomised controlled trials. A 2013 study by Talbott et al. in the Journal of the International Society of Sports Nutrition found that 200 mg/day of this standardised extract significantly improved stress hormone profiles, reducing cortisol by 16% and increasing testosterone by 37%, in moderately stressed adults over four weeks. A 2012 study by Ismail et al. in Evidence-Based Complementary and Alternative Medicine found meaningful improvements in sexual well-being scores among men with late-onset hypogonadism. A 2014 study by Henkel et al. in Phytotherapy Research extended the supportive evidence base to 400 mg/day in physically active seniors. These are real studies with real effect sizes using a chemically characterised extract.

Red Flags in Labelling: A Literacy Guide

Learning to read a Tongkat Ali label critically is, in my view, a basic consumer health skill that every Singaporean supplement buyer should develop. Here is what to look for — and what to run from.

Red flag: Extract ratio without biomarker specification. As established above, “1:100” or “1:200” without a stated eurycomanone percentage means nothing. Any product leading with extract ratio as its primary potency claim is almost certainly obscuring the absence of meaningful standardisation.

Red flag: No manufacturer country of origin or facility details. Genuine quality manufacturers — Biotropics Malaysia (Physta®), LJ100® (MIT-licensed extract by HP Ingredients), and others — are proud of their origin and manufacturing credentials. If a label lists no facility, no country of origin beyond vague “Southeast Asia,” and no GMP certification, the supply chain transparency required for a premium product is absent.

Red flag: Implausibly low price. Genuine, certified, standardised Tongkat Ali extract is expensive to produce. GMP manufacturing, third-party testing, and standardisation processes carry real costs. A product retailing at SGD 20 for 60 capsules cannot, as a matter of arithmetic, contain clinically relevant doses of a properly produced standardised extract. It can contain something labelled Tongkat Ali. Whether that something bears meaningful biochemical relationship to the compound studied in clinical trials is a different question entirely.

Red flag: Proprietary blends hiding individual doses. A product listing a “Men’s Power Blend: Tongkat Ali, Maca, Tribulus, Ginseng — 500 mg total” cannot tell you whether it contains 450 mg of filler and 10 mg of Tongkat Ali. This is a legal and widespread practice that functionally allows manufacturers to claim the presence of premium ingredients at doses too low to have any effect.

Red flag: Claims to be “HSA-approved.” The HSA lists supplements; it does not approve them in the clinical sense. A product claiming HSA approval as a marker of efficacy is misrepresenting the regulatory framework. Listing means the product has been registered, not validated.

The Checklist: How to Identify a Premium Tongkat Ali Product

After years of reviewing the evidence base and consulting with patients across Singapore’s supplement-saturated market, I have developed what I consider a reliable five-point framework for identifying genuine quality.

1. Named, standardised extract with eurycomanone specification. Look for Physta®, LJ100®, or a clearly stated eurycomanone content of at least 0.8–1%. These are the only forms with consistent clinical evidence behind them. If the extract has no name and no biomarker specification, move on.

2. Verified manufacturing credentials. GMP (Good Manufacturing Practice) certification from a recognised body — NSF, TGA, BFAD, or equivalent — should be stated on the label or verifiable on the manufacturer’s website. Malaysian Ministry of Health certification for the raw extract source is a strong additional positive indicator.

3. Third-party testing documentation. A credible brand will provide a Certificate of Analysis (CoA) from an independent laboratory confirming bioactive content, heavy metal testing, microbial testing, and pesticide residue limits. If this is not available on request, it does not exist.

4. Transparent, clinical dosing. The evidence-backed daily range for standardised Tongkat Ali extract (Physta® basis) is 200–400 mg per day, with 200 mg the most-replicated baseline and 400 mg the upper end of the routinely-evidenced daily window. Around 600 mg sits at the upper clinical ceiling for shorter-term, cycled use; doses above 600 mg are experimental and have not been validated in long-term human RCTs. Products providing significantly less than 200 mg of a properly standardised extract are likely underdosing to reduce costs while maintaining label claims. Products providing dramatically more than 400 mg daily are not necessarily better — and may not have clinical data supporting the higher dose.

5. HSA-listed with traceable seller. While HSA listing is not a mark of efficacy, it does establish a baseline of regulatory accountability. Buy from authorised retailers — brick-and-mortar pharmacies, brand-owned Shopee flagship stores, or authorised resellers listed on the manufacturer’s official website — rather than anonymous third-party listings.

A Broader Observation: Why This Matters Beyond Testosterone

Tongkat Ali is, in some respects, a case study for the wider problem of supplement quality in Singapore. The same pattern — genuine underlying evidence, legitimate clinical applications, a small number of well-manufactured products, and a vast ocean of low-quality imitations riding on borrowed credibility — repeats itself across ashwagandha, curcumin, berberine, lion’s mane, and NMN.

The consumer’s challenge is identical in each case: the ingredient works when used correctly, and the market makes it very difficult to use it correctly.

I believe the solution requires action on two fronts. First, from the HSA and Ministry of Health: stricter labelling requirements mandating biomarker content declaration for herbal extracts — not merely ingredient listing — would represent a meaningful step toward consumer protection. The EU’s framework under the European Medicines Agency’s HMPC guidelines, which requires characterisation of herbal extracts beyond simple ratio claims, offers a model worth examining.

Second, from consumers: the willingness to invest in quality. The total cost of taking clinically irrelevant Tongkat Ali for three months — in money, time, and the erosion of faith in a genuinely useful ingredient — exceeds the cost difference between a poor product and a good one. This is perhaps the most direct argument against the perpetual search for the cheapest option. In supplement quality, as in most things, the Singaporean instinct for value should be applied not to price but to evidence-per-dollar.

Conclusion

Tongkat Ali is not a myth. The compound, when properly standardised and correctly dosed, has a legitimate and growing evidence base for stress modulation, hormonal support, and male reproductive health. What is mythological is the idea that any capsule labelled “Tongkat Ali” on a Shopee listing delivers those benefits.

A product containing certified Physta® extract through a registered pharmacy would, after eight weeks at the correct dose, give more energy and better stress tolerance.

Know what you are buying. Read the label like a scientist. Spend the extra thirty dollars.

Frequently Asked Questions

What does the extract ratio “1:200” actually mean?

It means that 200 kg of raw Tongkat Ali root were processed to yield 1 kg of finished extract. Counter to widespread consumer intuition, a higher ratio is not a reliable indicator of higher potency — extract ratios are largely a marketing convention, not a clinical specification. A high ratio can just as easily reflect low-quality starting root, aggressive processing that destroys fragile bioactives, or simple over-concentration as it can reflect genuine concentration of active compounds. What actually determines potency is standardisation — the stated percentage of eurycomanone, glycosaponins, and bioactive peptides in the final extract. Physta®, the most clinically studied form, sits at a ratio of around 1:20 or less, deliberately, because its potency comes from preserving and quantifying bioactives rather than from headline concentration.

What is the difference between Physta® and LJ100®?

Both are standardised Tongkat Ali extracts with substantial peer-reviewed clinical evidence behind them. Physta® is a freeze-dried hot-water extract developed by Biotropics Malaysia in collaboration with MIT, standardised to 0.8–1.5% eurycomanone alongside defined glycosaponin and bioactive-peptide content. LJ100® is an extract developed through a related MIT-licensed pathway. Both meet the clinical-grade biomarker standards that distinguish credible standardised extracts from generic root powder.

How much Tongkat Ali should I take per day?

The evidence-backed daily range for a standardised extract is 200–400 mg, with 200 mg the most-replicated baseline across Physta® RCTs and 400 mg the upper end of the routinely-evidenced daily window. Around 600 mg sits at the upper clinical ceiling for shorter-term, cycled use; doses above 600 mg are experimental and lack supporting long-term human data.

What is HSA notification — and does it mean the product works?

HSA notification means the product has been registered with Singapore’s Health Sciences Authority under the Complementary Health Products (CHP) framework. It is a baseline regulatory checkpoint, not a clinical efficacy endorsement. A product can be HSA-notified and still be a poorly standardised, underdosed preparation. Notification establishes accountability; it does not establish quality. Always combine HSA notification with the other four checks in this article.

Are the cheap Tongkat Ali products on Shopee safe to take?

Safety risk and efficacy risk are different questions. Most very-cheap products are not acutely dangerous — Tongkat Ali itself has a wide safety margin (with an oral LD50 of approximately 3,000 mg/kg of body weight in rodents for water-based extract, orders of magnitude above any human dose). The risk is twofold: first, that the product contains so little active bioactive that it does nothing therapeutically; and second, that the supply chain is not controlled for adulteration (the Malaysian NPRA has documented Tongkat Ali products spiked with undeclared synthetic PDE-5 inhibitors). The safe assumption with an unverified Shopee product is that you don’t know what you’re taking.

References

Biotropics Malaysia. (2023). Physta® Tongkat Ali standardised water-soluble extract: Product and research overview. Biotropics Malaysia Berhad. https://www.biotropics.com.my/physta

European Medicines Agency, Committee on Herbal Medicinal Products. (2014). Guideline on specifications: Test procedures and acceptance criteria for herbal substances, herbal preparations and herbal medicinal products/traditional herbal medicinal products. EMA/HMPC. https://www.ema.europa.eu/en/guideline-specifications-test-procedures-acceptance-criteria-herbal-substances-herbal-preparations

George, A., & Henkel, R. (2014). Phytoandrogenic properties of Eurycoma longifolia as a natural alternative to testosterone replacement therapy. Andrologia, 46(7), 708–721. https://doi.org/10.1111/and.12214

Health Sciences Authority Singapore. (2023). Listing of health supplements in Singapore. HSA. https://www.hsa.gov.sg/health-products-regulation/health-supplements

Henkel, R. R., Wang, R., Bassett, S. H., Chen, T., Liu, N., Zhu, Y., & Tambi, M. I. M. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors: A pilot study. Phytotherapy Research, 28(4), 544–550. https://doi.org/10.1002/ptr.5017

Ismail, S. B., Wan Mohammad, W. M. Z., George, A., Nik Hussain, N. H., Musthapa Kamal, Z. M., & Liske, E. (2012). Randomized clinical trial on the use of PHYSTA® freeze-dried water extract of Eurycoma longifolia for the improvement of quality of life and sexual well-being in men. Evidence-Based Complementary and Alternative Medicine, 2012, 429268. https://doi.org/10.1155/2012/429268

Leisegang, K., Finelli, R., Sikka, S. C., & Panner Selvam, M. K. (2022). Eurycoma longifolia (Jack) improves sexual dysfunction in men: A systematic review. Medicina, 58(1), 67. https://doi.org/10.3390/medicina58010067

Li, C. H., Liao, J. W., Liao, P. L., Huang, W. K., Tse, L. S., Lin, C. H., Kang, J. J., & Cheng, Y. W. (2013). Evaluation of acute 13-week subchronic toxicity and genotoxicity of the powdered root of Tongkat Ali (Eurycoma longifolia Jack). Evidence-Based Complementary and Alternative Medicine, 2013, 102987. https://doi.org/10.1155/2013/102987

Low, B. S., Choi, S. B., Abdul Wahab, H., Das, P. K., & Chan, K. L. (2013). Eurycomanone, the major quassinoid in Eurycoma longifolia root extract, exerts its effects on steroidogenesis at the level of steroidogenic acute regulatory protein. Journal of Ethnopharmacology, 150(2), 648–655. https://doi.org/10.1016/j.jep.2013.09.011

Ministry of Health Malaysia. (2021). Malaysian Herbal Monograph: Eurycoma longifolia (Tongkat Ali). MOH Malaysia. https://www.pharmacy.gov.my

Talbott, S. M., Talbott, J. A., George, A., & Pugh, M. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10(1), 28. https://doi.org/10.1186/1550-2783-10-28

Tambi, M. I. B. M., Imran, M. K., & Henkel, R. R. (2012). Standardised water-soluble extract of Eurycoma longifolia, Tongkat Ali, as testosterone booster for managing men with late-onset hypogonadism. Andrologia, 44(Suppl. 1), 226–230. https://doi.org/10.1111/j.1439-0272.2011.01168.x

Udani, J. K., George, A. A., & Musthapa, M. (2014). Effects of a proprietary freeze-dried water extract of Eurycoma longifolia (Physta®) and Polygonum minus on sexual performance and well-being in men: A randomized, double-blind, placebo-controlled study. Evidence-Based Complementary and Alternative Medicine, 2014, 179529. https://doi.org/10.1155/2014/179529